** Shares of EMVision Medical Devices rise as much as 17.7% to A$2.1, their best trading session since early March

** Shares hit their highest level since Oct. 22

** Medical equipment and tech co reports successful results from its neurodiagnostic technology for early identification of stroke and stroke types

** Says study highlights sensing capabilities, including successful detection and classification of very small haemorrhages

** Adds AI-based diagnostic models demonstrated improved performance as additional clinical data was provided

** More than 78,000 shares change hands vs 30-day avg volume of around 35,000 shares

** YTD, EMV up 21.5% as of 0100 GMT

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com))